NC
ARVN icon

nVerses Capital’s Arvinas ARVN Stock Holding History

nVerses Capital’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,600
Closed -$39.4K – 68
2024
Q3 		$39.4K Buy
+1,600
New +$41.8K 0.02% 695

Other funds holding ARVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

nVerses Capital's ARVN Position: Q4 2024 in Review

nVerses Capital sold out of Arvinas (ARVN) in Q4 2024, closing a stake of 1,600 shares — an estimated $39.4K sold.

nVerses Capital first reported a position in ARVN in Q3 2024 and held it in 1 quarter. The position peaked at $39.4K in Q3 2024. 198 funds tracked by Wall St. Rank hold ARVN as of Q4 2024.

  • nVerses Capital reported no remaining Arvinas position as of Q4 2024 after selling out during the quarter.
  • nVerses Capital sold 1,600 Arvinas shares in Q4 2024, an estimated $39.4K.
  • nVerses Capital first reported a position in Arvinas in Q3 2024 and held it in 1 quarter.
  • nVerses Capital's Arvinas position peaked at $39.4K in Q3 2024.
  • 198 funds tracked by Wall St. Rank held Arvinas as of Q4 2024.

Based on nVerses Capital's 13F filing for Q4 2024.